Your session is about to expire
← Back to Search
Cognitive Training for Breast Cancer
Study Summary
This trial will study whether a cognitive training program can help older adults with breast cancer who are receiving chemotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently undergoing or about to start systemic therapy for breast cancer, with at least two cycles left.I am 65 years old or older.I am scheduled for surgery within the next 3 months.I have been diagnosed with invasive breast cancer.I cannot make health decisions and do not have a health care proxy.I am not on endocrine therapy alone for my breast cancer.
- Group 1: Supportive therapy (time and attention control)
- Group 2: MAAT-G intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any remaining slots open for those seeking to participate in this research endeavor?
"ClinicalTrials.gov indicates that this trial is actively searching for participants, with the initial posting occurring on April 2nd 2021 and the most recent update taking place January 14th 2022."
What are the fundamental points of inquiry for this research project?
"The primary endpoint of this trial, to be monitored over a two-week period post-intervention, is the Experience Interview. Secondary outcomes include Geriatric Depression Screen (GDS), Generalized Anxiety and Depression 7-item scale (GAD-7) and Instrumental Activities of Daily Living (IADL). The GDS assesses emotional states through 15 'yes' or 'no' questions that present both positively and negatively; the GAD-7 evaluates anxiety levels with seven 0 - 3 ranked queries; while IADL examines functional independence on an unnumbered scale from most to least independent."
How many participants have been deemed eligible for this clinical experiment?
"Affirmative. According to information sourced from clinicaltrials.gov, this research venture is open for recruitment; it was first shared on April 2nd 2021 and updated January 14th 2022. Eighty-five participants need to be recruited across a single trial site."
Share this study with friends
Copy Link
Messenger